Intellia Therapeutics, Inc. — Form D

Intellia Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-03. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2015-09-03
• Form: D
• Accession: 0001652130-15-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $70.0M
• Amount sold: $70.0M
• Investors: 28
• Date of first sale: 2015-08-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-247004

Issuer

• Name: Intellia Therapeutics, Inc.
• CIK: 0001652130
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 130 BROOKLINE STREET, CAMBRIDGE, MA, 02139
• Phone: 857-285-6200

Officers, directors & promoters (8)

More

• CIK 1652130 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search